RF76. R+ Resection for Clinical Stage III Non-Small Cell Lung Cancer: Should We Have Just Given Chemoradiation?
The Journal of Thoracic and Cardiovascular Surgery · 2026-05 · 171 (4) · S162
DOI: 10.1016/j.jtcvs.2026.03.524 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Thoracic and Cardiovascular Surgery, 2026-05. Verfasst von Grace Ha und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Ha, G., Ostrovetsky, O., Nobel, T., Vimolratana, M., Stiles, B., & Chudgar, N. (2026). RF76. R+ Resection for Clinical Stage III Non-Small Cell Lung Cancer: Should We Have Just Given Chemoradiation?. The Journal of Thoracic and Cardiovascular Surgery, 171(4), S162. https://doi.org/10.1016/j.jtcvs.2026.03.524
Vancouver
Ha G, Ostrovetsky O, Nobel T, Vimolratana M, Stiles B, Chudgar N. RF76. R+ Resection for Clinical Stage III Non-Small Cell Lung Cancer: Should We Have Just Given Chemoradiation?. The Journal of Thoracic and Cardiovascular Surgery. 2026;171(4):S162. doi:10.1016/j.jtcvs.2026.03.524
BibTeX
@article{Ha2026,
author = {Ha, Grace and Ostrovetsky, Olga and Nobel, Tamar and Vimolratana, Marc and Stiles, Brendon and Chudgar, Neel},
title = {RF76. R+ Resection for Clinical Stage III Non-Small Cell Lung Cancer: Should We Have Just Given Chemoradiation?},
journal = {The Journal of Thoracic and Cardiovascular Surgery},
year = {2026},
volume = {171},
number = {4},
pages = {S162},
doi = {10.1016/j.jtcvs.2026.03.524}
}
EUVIMED